Please login to the form below
Elliott Levy joins Amgen from BMS
He is appointed senior VP, global development
Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.
Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.
During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.
“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.
“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- Communique - Communiqué Awards
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- AI and accelerated computing ring in new era for healthcare
- Sinovac’s COVID-19 vaccine appears safe in older adults
- FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
- Sanofi, Regeneron’s Libtayo scores first-line NSCLC approval in the US
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- WHO agrees to no-fault compensation for rare serious side effects from COVAX-distributed vaccines
- Reaching patients and HCPs during the pandemic
- #DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
- #DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
- Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
- Looking back at the year when everything changed
- COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....
Quick links
Infographics
